177 related articles for article (PubMed ID: 22370309)
1. [Combination or sequential treatment using PTH and anti-resorption therapies].
Suzuki H; Takeuchi Y
Clin Calcium; 2012 Mar; 22(3):415-20. PubMed ID: 22370309
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Cosman F; Eriksen EF; Recknor C; Miller PD; GuaƱabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
[TBL] [Abstract][Full Text] [Related]
3. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
Nakatoh S
J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
[TBL] [Abstract][Full Text] [Related]
4. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
5. [Evidence for osteoporosis treatment using PTH (1-34) daily subcutaneous injection].
Yamamoto T; Hamaya E; Sowa H
Clin Calcium; 2012 Mar; 22(3):399-406. PubMed ID: 22370307
[TBL] [Abstract][Full Text] [Related]
6. [Evidence in the treatment of osteoporosis using weekly teriparatide injections].
Nakamura Y
Clin Calcium; 2012 Mar; 22(3):407-13. PubMed ID: 22370308
[TBL] [Abstract][Full Text] [Related]
7. [Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
Ono K; Ohashi S; Tanaka S
Clin Calcium; 2014 Mar; 24(3):401-6. PubMed ID: 24576937
[TBL] [Abstract][Full Text] [Related]
8. [To where and until when handle the osteoporosis?].
Uebelhart B; Ferrari S
Rev Med Suisse; 2017 Apr; 13(559):859-862. PubMed ID: 28727344
[TBL] [Abstract][Full Text] [Related]
9. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
[TBL] [Abstract][Full Text] [Related]
10. [Combination therapy for osteoporosis].
Kishimoto H
Nihon Rinsho; 2009 May; 67(5):975-9. PubMed ID: 19432119
[TBL] [Abstract][Full Text] [Related]
11. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
Cosman F
Curr Osteoporos Rep; 2014 Dec; 12(4):385-95. PubMed ID: 25341476
[TBL] [Abstract][Full Text] [Related]
12. Oral antiresorptive therapy.
Pande I; Hosking DJ
Curr Rheumatol Rep; 2005 Mar; 7(1):71-7. PubMed ID: 15760584
[TBL] [Abstract][Full Text] [Related]
13. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
14. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.
Li YF; Li XD; Bao CY; Chen QM; Zhang H; Hu J
Osteoporos Int; 2013 Mar; 24(3):1063-71. PubMed ID: 23296744
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, effectiveness and side effects of medications used to prevent fractures.
Reid IR
J Intern Med; 2015 Jun; 277(6):690-706. PubMed ID: 25495429
[TBL] [Abstract][Full Text] [Related]
16. Short-term daily teriparatide in patients with rheumatoid arthritis.
Kaneko T; Okamura K; Yonemoto Y; Okura C; Suto T; Tachibana M; Tamura Y; Inoue M; Chikuda H
Mod Rheumatol; 2018 May; 28(3):468-473. PubMed ID: 28805099
[TBL] [Abstract][Full Text] [Related]
17. [Effects of parathyroid hormone (teriparatide) on bone quality in osteoporosis].
Saito M; Marumo K
Clin Calcium; 2012 Mar; 22(3):343-55. PubMed ID: 22370301
[TBL] [Abstract][Full Text] [Related]
18. [Effect and role of teriparatide in the treatment of osteoporosis].
Nakamura T
Clin Calcium; 2012 Mar; 22(3):309-14. PubMed ID: 22370296
[TBL] [Abstract][Full Text] [Related]
19. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
Cosman F; Nieves JW; Dempster DW
J Bone Miner Res; 2017 Feb; 32(2):198-202. PubMed ID: 27925287
[TBL] [Abstract][Full Text] [Related]
20. Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: comparison of bone metabolism marker levels.
Watanabe A; Tsurui K; Yoneyama S; Iwata H; Anzai T; Jerome C; Nakae D
J Toxicol Sci; 2018; 43(7):435-442. PubMed ID: 29973475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]